IT8648200A0 - Derivati benzimidazolici utili come agenti antiulcera - Google Patents

Derivati benzimidazolici utili come agenti antiulcera

Info

Publication number
IT8648200A0
IT8648200A0 IT8648200A IT4820086A IT8648200A0 IT 8648200 A0 IT8648200 A0 IT 8648200A0 IT 8648200 A IT8648200 A IT 8648200A IT 4820086 A IT4820086 A IT 4820086A IT 8648200 A0 IT8648200 A0 IT 8648200A0
Authority
IT
Italy
Prior art keywords
antiulcera
agents
benzimidazole derivatives
derivatives useful
benzimidazole
Prior art date
Application number
IT8648200A
Other languages
English (en)
Other versions
IT1208460B (it
Inventor
Kise Masahiro
Ueda Fusao
Tada Shinichi
Murase Masao
Kunimoto Katsutoshi
Sugiyama Makoto
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of IT8648200A0 publication Critical patent/IT8648200A0/it
Application granted granted Critical
Publication of IT1208460B publication Critical patent/IT1208460B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT8648200A 1985-07-03 1986-06-30 Derivati benzimidazolici utili come agenti antiulcera IT1208460B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60146925A JPS625966A (ja) 1985-07-03 1985-07-03 ベンズイミダゾ−ル誘導体

Publications (2)

Publication Number Publication Date
IT8648200A0 true IT8648200A0 (it) 1986-06-30
IT1208460B IT1208460B (it) 1989-06-12

Family

ID=15418672

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8648200A IT1208460B (it) 1985-07-03 1986-06-30 Derivati benzimidazolici utili come agenti antiulcera

Country Status (6)

Country Link
US (1) US4769384A (it)
JP (1) JPS625966A (it)
DE (1) DE3622036A1 (it)
FR (1) FR2587341B1 (it)
GB (1) GB2177393B (it)
IT (1) IT1208460B (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418245A (en) * 1990-04-16 1995-05-23 Rhone-Poulenc Rorer International (Holdings) Inc. Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase
US5196446A (en) * 1990-04-16 1993-03-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Certain indole compounds which inhibit EGF receptor tyrosine kinase
US5302606A (en) * 1990-04-16 1994-04-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase
US5656655A (en) * 1994-03-17 1997-08-12 Rhone-Poulenc Rorer Pharmaceuticals, Inc. Styryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinase
AU722514B2 (en) 1995-12-28 2000-08-03 Fujisawa Pharmaceutical Co., Ltd. Benzimidazole derivatives
KR20000022398A (ko) * 1996-07-05 2000-04-25 모치다 에이 신규 벤조이미다졸 유도체
TW453999B (en) 1997-06-27 2001-09-11 Fujisawa Pharmaceutical Co Benzimidazole derivatives
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
PL1606261T3 (pl) 2003-03-10 2010-04-30 Astrazeneca Ab Nowy sposób przygotowania roflumilastu
ES2421916T3 (es) 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
SI2799427T1 (sl) 2006-07-05 2018-12-31 Fibrotech Therapeutics Pty Ltd Terapevtske spojine
NZ595775A (en) * 2008-12-26 2013-07-26 Glenmark Pharmaceuticals Sa Fused imidazole derivatives as trpv3 antagonist
SG10201401169QA (en) * 2009-04-02 2014-05-29 Merck Serono Sa Dihydroorotate dehydrogenase inhibitors
US8323805B2 (en) 2009-06-04 2012-12-04 Nitto Denko Corporation Emissive aryl-heteroaryl acetylenes
US8420235B2 (en) * 2009-06-04 2013-04-16 Nitto Denko Corporation Emissive diaryl acetylenes
CN102574843B (zh) * 2009-10-22 2015-06-17 法博太科制药有限公司 抗纤维化剂的稠环类似物
CA3052036A1 (en) 2017-02-03 2018-08-09 Certa Therapeutics Pty Ltd. Anti-fibrotic compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2170474A (en) * 1936-03-18 1939-08-22 Soc Of Chemical Ind Benzimidazoles and process of making same
US3075991A (en) * 1960-01-20 1963-01-29 Dow Chemical Co Benzimidazolylalkylbenzene-sulfonamide compounds
US3152142A (en) * 1962-05-24 1964-10-06 Dow Chemical Co Benzimidazole compounds
FR1488318A (fr) * 1966-04-27 1967-07-13 Chimetron Sarl Dérivés sulfénylés de vinylbenzimidazoles
DE1670908A1 (de) * 1967-08-16 1971-04-29 Hoechst Ag Neue Benzimidazolverbindungen,Verfahren zu ihrer Herstellung und ihre Verwendung als optische Aufhellungsmittel
CH490010A (de) * 1967-10-26 1970-05-15 Ciba Geigy Schädlingsbekämpfungsmittel
DE2060939A1 (de) * 1970-12-11 1972-06-15 Agfa Gevaert Ag Spektral sensibilisiertes photographisches Schnellverarbeitungsmaterial
DE2320528A1 (de) * 1973-04-21 1974-11-07 Hoechst Ag Verfahren zur herstellung von acetylenen
JPS5020080A (it) * 1973-06-06 1975-03-03
JPS51125078A (en) * 1974-07-01 1976-11-01 Lilly Co Eli Production of substituted 11sulphonylbenzimidazole
GB2053215B (en) * 1979-06-25 1983-04-07 May & Baker Ltd Benzimidazole derivatives

Also Published As

Publication number Publication date
GB8614420D0 (en) 1986-07-16
IT1208460B (it) 1989-06-12
US4769384A (en) 1988-09-06
DE3622036A1 (de) 1987-01-22
JPS625966A (ja) 1987-01-12
GB2177393A (en) 1987-01-21
JPH0550512B2 (it) 1993-07-29
FR2587341A1 (fr) 1987-03-20
FR2587341B1 (fr) 1990-05-25
GB2177393B (en) 1989-02-01

Similar Documents

Publication Publication Date Title
DK263587A (da) Imidazoquinolinyletherderivater
ATA312487A (de) Tetrahydrocarbazolonderivate
IT8648200A0 (it) Derivati benzimidazolici utili come agenti antiulcera
IT1190385B (it) Derivati di etilendiamminomonoammidi
DK9987A (da) Ethanolaminderivater
DK693587A (da) Alkansulfonanilidderivater
MC1771A1 (fr) Derives de benzimidazole
IT1203608B (it) Derivati di prolina
IT1231238B (it) Derivati ammidinici
DK691287D0 (da) 5-floururacilderivater
DK210487A (da) Substituerede benzimidazolderivater
DK569786D0 (da) Benzimidazolderivater
DK444687D0 (da) Alfa-substituerede ketonitron-derivater
IT1164233B (it) Derivati pirazolici utili come erbicidi
DK405988D0 (da) Benzimidazolderivater
DK440687D0 (da) Bicyclooctanderivater
DK229887D0 (da) Alkenamidderivater
DK619187A (da) Isoindolderivater
IT1194021B (it) Derivati di imidazol-idrazoni utili come farmaci
DK688187D0 (da) Imidazol- og triazolderivater til anvendelse som antimycotiske midler
FR2610498B1 (fr) Treteau
DK435087D0 (da) Isoprenderivater
IT1183330B (it) Derivati di fenilpropargilammine
DK440787A (da) Bicyclooctanderivater
DK691087D0 (da) Dioxazocinderivater